Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Methodological standard · §6

CEI-MS-07 — worked example

A worked calculation, and an illustrative mass balance showing what a purity figure alone does not establish.

Document identifier
CEI-MS-07/6
Series
Methodological standard
Version
1.1
Published
24 Oct 2024
Last reviewed
24 Jul 2025
Next review
24 Jul 2028
Identifier
10.71829/cei.meth.7
Certainty
High
Cycle
2024 Q4
Category
Physical quality

§6Worked example

§6.1Worked example — why the small-volume limit is per container, not per millilitre

  1. A 2 mL reconstituted solution gives light-obscuration counts of 2 850 particles ≥ 10 µm and 180 ≥ 25 µm per millilitre.
  2. Per container: 2 850 × 2 = 5 700 particles ≥ 10 µm and 180 × 2 = 360 ≥ 25 µm.
  3. Both fall below the small-volume limits of 6 000 and 600 per container, so the preparation complies.
  4. Now reconstitute the identical vial with 5 mL instead. If the particle burden is intrinsic to the solid and not to the diluent, the total count per container is unchanged at roughly 5 700, but the per-millilitre count falls to 1 140.
  5. A laboratory reporting a per-millilitre figure against a per-container limit would record the 5 mL preparation as five times better than the 2 mL one, when they contain the same particles. The limit is stated per container precisely because that is the quantity administered, and the Institute records mis-stated units as one of the recurring errors in submitted data.

§6.2Illustrative mass balance

References cited on this page

References are numbered in order of first citation in this document. Each superscript in the text links to its entry below.

  1. United States Pharmacopeial Convention. General Chapter ⟨788⟩ Particulate Matter in Injections. United States Pharmacopeia — National Formulary (USP–NF) 2024;USP 2024 Issue 1. identifier not held by the Institute
  2. United States Pharmacopeial Convention. General Chapter ⟨1225⟩ Validation of Compendial Procedures. United States Pharmacopeia — National Formulary (USP–NF) 2024;USP 2024 Issue 1. identifier not held by the Institute

Identifiers are reproduced only where the Institute holds them. Where a digital object identifier or PubMed identifier is not shown, the Institute has recorded the journal and year and has not constructed an identifier.

Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.